Then HK$565 per month. Complete digital access to quality FT journalism on any device. Cancel anytime during your trial.
To bring FLASH therapy out of the lab and into clinical use, researchers like Vozenin and Loo needed machines capable of delivering fast, high doses with pinpoint precision deep inside the body. Most early studies relied on low-energy electron beams like Favaudon’s 4.5-megaelectron-volt Kinetron—sufficient for surface tumors, but unable to reach more than a few centimeters into a human body. Treating deep-seated cancers in the lung, brain, or abdomen would require far higher particle energies.。关于这个话题，新收录的资料提供了深入分析
。关于这个话题，新收录的资料提供了深入分析
Последние новости，推荐阅读新收录的资料获取更多信息
FT Edit: Access on iOS and web